ARCpoint Shares Halted at $0.10 After July 29 Filing Miss

For shareholders of micro-cap ARCpoint, the sudden trading halt is more than an inconvenience—it's a liquidity trap. With shares frozen at just C$0.10, the lack of disclosure surrounding the company's financial position makes it impossible to assess the actual value of their investment.

The British Columbia Securities Commission (BCSC) has issued a failure-to-file cease trade order against ARCpoint Inc. (TSXV: ARC), effective August 5, 2026, after the company failed to submit its audited annual financial statements, management’s discussion and analysis (MD&A), and CEO/CFO certifications for the fiscal year ended March 31, 2026. The filing deadline was July 29, 2026, and the company’s failure triggered the regulatory action under National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

“

With shares frozen at just C$0.10, the lack of disclosure surrounding the company's financial position makes it impossible to assess the actual value of their investment.

This cease trade order freezes all trading in ARCpoint’s securities in Canada and, under the reciprocity provisions of NP 11-207, can be recognized in other jurisdictions where the shares trade. For a micro-cap company like ARCpoint, which operates in the drug and alcohol testing industry, the halt chokes off liquidity at a vulnerable moment. Investors are suddenly trapped in a position with no ability to exit, and the company faces immediate reputational and operational strain. Without a tradable security, raising capital becomes extremely difficult, and existing business relationships may fracture.

The regulatory framework behind the order is designed to protect market integrity. Canadian securities law mandates continuous disclosure to ensure investors have access to timely and accurate information. The annual financial statements and MD&A provide a critical window into a company’s health. When an issuer misses this deadline, the principal regulator can issue a cease trade order after a brief warning period—a relatively streamlined process under NP 11-207. The order is not punitive in itself but a mechanism to halt trading until the required information is available to the public. Once ARCpoint files the overdue documents and they are accepted by the BCSC, the cease trade order can be revoked, typically within days.

However, the consequences of failing to rectify the situation are severe. Under NP 11-207, if the filings are not made within 90 days of the order, the cease trade order becomes permanent, exposing the company to potential delisting by the TSX Venture Exchange and additional enforcement actions. These could include management cease trade orders that personally bar directors and officers from trading in the company’s securities, or monetary penalties. Furthermore, the opacity created by the missing filings may hide deeper financial distress. Without the audited numbers, investors cannot assess solvency, liquidity, or operational performance.

ARCpoint has not disclosed why it missed the deadline. Common reasons include auditor resignations, internal control deficiencies, or more serious accounting irregularities. The announcement merely states that the company is working to complete the filings, but no timeline is given. This lack of clarity compounds uncertainty. The stock, which last traded at a likely nominal price given its micro-cap status, now sits frozen, and any existing shareholder lawsuits or credit defaults could be triggered by the default.